Madinette

Chlormadinone acetate and ethinylestradiol, the active ingredients in Madinette, are a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age by suppressing ovulation, thickening cervical mucus and altering the endometrium, and the product complies with EU regulatory standards and is prescribed by qualified healthcare professionals.

GNH USA supplies Madinette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. It is contraindicated during pregnancy and requires medical assessment before initiation.

Madinette, a combined estrogen‑progestogen oral contraceptive, is used to prevent pregnancy and manage related menstrual conditions.

- Prevention of pregnancy: delivers consistent hormonal suppression to inhibit ovulation, offering reliable contraceptive protection for women of childbearing potential. - Regulation of menstrual cycles: stabilises hormonal fluctuations, leading to more predictable cycle length, reduced irregular bleeding and lighter periods. - Treatment of moderate acne: decreases androgen‑mediated sebum production, improving skin clarity in women with hormonally influenced acne. - Management of dysmenorrhea: alleviates painful menstrual cramps through hormonal modulation.

Madinette may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Breast tenderness - Headache - Weight gain - Breakthrough bleeding

Serious or Rare Side Effects: - Venous thromboembolism - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension - Hepatic adenoma or other liver disorders

Before prescribing Madinette, clinicians should evaluate several safety considerations.

- Contraindicated in pregnancy: the product must not be used by pregnant women. - Smoking in women over 35 years: increases risk of cardiovascular events; advise cessation. - History of thromboembolic disease: avoid due to elevated clotting risk. - Uncontrolled hypertension: requires blood pressure control prior to use. - Liver disease: impaired metabolism may alter drug levels. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and light.

Madinette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive effectiveness. - Anticoagulants (warfarin): may increase INR and bleeding risk. - Antiepileptic drugs (phenytoin, phenobarbital): decrease hormone levels, compromising contraception.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline or fluoroquinolones: may slightly lower contraceptive reliability. - Selective serotonin reuptake inhibitors (SSRIs): can increase nausea when combined. - Herbal supplements (St. John’s wort): may reduce hormonal concentrations. - Antifungal agents (ketoconazole): may increase hormone levels, raising side‑effect risk.